Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockView Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Discovery themes featuring this stock
CARE Ratings Ltd (CARERATING) is currently trading at 1,625.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
CareEdge (CARE Ratings Limited) is an India‑based knowledge and analytics group that provides credit ratings, analytics, consulting and sustainability services; it is India’s second‑largest credit rating agency with a group of subsidiaries covering analytics, ESG ratings and global IFSC operations, serving corporates, financial institutions and international sovereign and debt issuers. Financial momentum is visible in Q3 and 9M FY26: consolidated revenue rose 16% in Q3 and 17% in 9M to Rs. 112.12 Cr and Rs. 342.40 Cr respectively, while consolidated PAT margin expanded to 32% for 9M FY26, reflecting disciplined cost management and broad‑based growth across ratings and non‑ratings businesses. Ratings remain the dominant revenue driver, contributing 89% of consolidated 9M FY26 revenue (Rs. 305.69 Cr), while the non‑ratings segment grew faster at 21% and now contributes 11% of consolidated revenue, indicating early diversification beyond traditional rating services towards analytics, advisory and ESG offerings. Strategic product and market expansion are evident: CareEdge launched CareEdge Global IFSC for global scale ratings, secured SEBI Category I license for CARE ESG Ratings, and commercialized EdgeAvira.ai, a Gen‑AI risk intelligence platform, all of which signal deliberate moves to expand addressable markets and monetize technology‑enabled services.
Over the past 52 weeks, CARE Ratings Ltd has traded between a low of ₹1,393.95 and a high of ₹1,836.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
CARE Ratings Ltd has a market capitalization of approximately 4,901.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
CARE Ratings Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 27.20 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 4,901.32 Cr, CARE Ratings Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
CARE Ratings Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of CARE Ratings Ltd is 27.20. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
CARE Ratings reported consolidated revenue of ₹111 crore and consolidated net profit of ₹33 crore for Q1 FY27 ended June 30, 2026.
The report said the stock rose after the company indicated its board would consider a proposal to buy back equity shares in a July 20 meeting.
Consolidated PAT rose to ₹52.83 crore in Q4 FY26, up 23.98% from ₹42.61 crore in Q4 FY25.
CARE Ratings upgraded Shriram Finance to 'AAA' due to its improved financial and operational performance, significantly bolstered by the strategic ₹39,618 crore investment from Japan's MUFG Bank.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
145.00 | 6,642 Cr | 59.56 | 1.11 | 4.41 | 3.04 | 5.04 | 1.73 | ||
101.00 | 6,170 Cr | 7.97 | 0.83 | 22.96 | 14.26 | 10.09 | 5.26 | ||
99.90 | 5,402 Cr | 40.92 | 1.08 | 9.05 | 4.18 | 6.63 | 2.33 | ||
225.90 | 4,973 Cr | 13.64 | 1.89 | 0.42 | 12.28 | 17.00 | 7.94 | ||
1618.00 | 4,901 Cr | 27.20 | 5.26 | 1.35 | 18.36 | 24.81 | 16.31 | ||
230.75 | 4,617 Cr | 21.14 | 6.19 | 1.73 | 27.33 | 34.46 | 26.68 | ||
4541.80 | 4,385 Cr | 22.35 | 3.71 | 2.31 | 15.37 | 21.19 | 13.20 | ||
| Median: 7 Co. | — | 225.90 | 4,973 Cr | 22.35 | 1.89 | 2.31 | 14.26 | 17.00 | 7.94 |
Bearish
3
Neutral
4
Bullish
7
Bearish
35
Neutral
4
Bullish
7
Bearish
32
Neutral
0
Bullish
0
Bearish
3
Neutral
4
Bullish
7
Bearish
3
Neutral
4
Bullish
7
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
CareEdge (CARE Ratings Limited) is an India‑based knowledge and analytics group that provides credit ratings, analytics, consulting and sustainability services; it is India’s second‑largest credit rating agency with a group of subsidiaries covering analytics, ESG ratings and global IFSC operations, serving corporates, financial institutions and international sovereign and debt issuers.
Financial momentum is visible in Q3 and 9M FY26: consolidated revenue rose 16% in Q3 and 17% in 9M to Rs. 112.12 Cr and Rs. 342.40 Cr respectively, while consolidated PAT margin expanded to 32% for 9M FY26, reflecting disciplined cost management and broad‑based growth across ratings and non‑ratings businesses.
Ratings remain the dominant revenue driver, contributing 89% of consolidated 9M FY26 revenue (Rs. 305.69 Cr), while the non‑ratings segment grew faster at 21% and now contributes 11% of consolidated revenue, indicating early diversification beyond traditional rating services towards analytics, advisory and ESG offerings.
Strategic product and market expansion are evident: CareEdge launched CareEdge Global IFSC for global scale ratings, secured SEBI Category I license for CARE ESG Ratings, and commercialized EdgeAvira.ai, a Gen‑AI risk intelligence platform, all of which signal deliberate moves to expand addressable markets and monetize technology‑enabled services.
Capital Markets
Ratings
4,894 Cr
Low Risk
27.2
38.1
1.8
5.3
1,836.00
1,393.95
Sales CAGR
Profit CAGR
ROE
ROCE
